Related Experiment Video
Updated: Nov 20, 2025

Analyzing the Functions of Mast Cells In Vivo Using 'Mast Cell Knock-in' Mice
Published on: May 27, 2015
Pediatric Mastocytosis: Recognition and Management
1Division of Pediatric Dermatology, Hackensack Meridian School of Medicine at Seton Hall University, 155 Polifly Road, Suite 101, Hackensack, NJ, 07601, USA. julie.schaffer@hmhn.org.
Childhood mastocytosis primarily affects the skin, unlike in adults. This review covers its molecular basis, diagnosis, and management, offering a practical guide for pediatric cases.
Area of Science:
- Pediatric Hematology
- Dermatology
- Molecular Genetics
Background:
- Mastocytosis involves clonal mast cell accumulation in various organs.
- Childhood mastocytosis predominantly presents as cutaneous disease, differing from adult presentations.
- Understanding pediatric mastocytosis is crucial for accurate diagnosis and management.
Purpose of the Study:
- To review the molecular pathogenesis of childhood mastocytosis.
- To detail skin findings, mediator-related symptoms, and diagnostic approaches.
- To provide management strategies and prognostic indicators for pediatric mastocytosis.
Main Methods:
- Review of current literature on childhood-onset mastocytosis.
- Analysis of classification, natural history, and clinical manifestations.
- Inclusion of an assessment algorithm and diagnostic techniques like allele-specific quantitative PCR (ASqPCR).
Main Results:
- Most pediatric mastocytosis cases are limited to the skin.
- Hepatosplenomegaly indicates systemic disease, detectable via ASqPCR for KIT mutations.
- Consensus-based recommendations for trigger avoidance and management are discussed.
Conclusions:
- Childhood mastocytosis requires a distinct approach from adult-onset disease.
- An individualized, stepwise management plan is essential.
- Early recognition and appropriate monitoring improve outcomes for pediatric patients.
More Related Videos
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
06:39Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...